Shanrong Biotechnology Corp. (SRBT)
USD 0.1
(0.0%)
USD 0.1
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 16.4 Thousand | 78.98 Thousand | - | - | - | 446.82 Thousand |
| Selling, General and Administrative Expenses | 16.4 Thousand | 78.98 Thousand | - | - | - | 223.41 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | 223.41 Thousand |
| Cost and Expenses | 16.4 Thousand | 78.98 Thousand | - | - | - | 446.82 Thousand |
| Operating Income | -16.4 Thousand | -78.99 Thousand | - | - | - | -446.82 Thousand |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -167.89 Thousand | -228.48 Thousand | - | - | - | -223.44 Thousand |
| Earnings before Tax | -16.4 Thousand | -78.98 Thousand | - | - | - | -223.44 Thousand |
| Net Income | -16.4 Thousand | -78.98 Thousand | - | - | - | - |
| Earnings Per Share Basic | -0.03 | -0.16 | - | - | - | - |
| Earnings Per Share Diluted | -0.03 | -0.16 | - | - | - | - |
| Weighted Average Shares Outstanding | 484.85 Thousand | 484.85 Thousand | 2.98 Million | 2.98 Million | 2.98 Million | 2.98 Million |
| Weighted Average Shares Outstanding (Diluted) | 484.85 Thousand | 484.85 Thousand | 2.98 Million | 2.98 Million | 2.98 Million | 2.98 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -16.4 Thousand | -78.99 Thousand | - | - | - | -446.82 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 5298.00 | 10.67 Thousand | 16.4 Thousand | 8746.00 | 3746.00 | 19.74 Thousand |
| Selling, General and Administrative Expenses | 5298.00 | 10.67 Thousand | - | 8746.00 | 3746.00 | 19.74 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 5298.00 | 10.67 Thousand | 16.4 Thousand | 8746.00 | 3746.00 | 19.74 Thousand |
| Operating Income | -5300.00 | -10.67 Thousand | -16.4 Thousand | -8750.00 | -3750.00 | -19.75 Thousand |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | -43.27 Thousand | -167.89 Thousand | 39.58 Thousand | -122.08 Thousand | -41.58 Thousand |
| Earnings before Tax | -5298.00 | -10.67 Thousand | -16.4 Thousand | -8746.00 | -3746.00 | -19.74 Thousand |
| Net Income | -5298.00 | -10.67 Thousand | -16.4 Thousand | -8746.00 | -3746.00 | -19.74 Thousand |
| Earnings Per Share Basic | -0.00 | -0.02 | - | -0.02 | -0.01 | -0.04 |
| Earnings Per Share Diluted | -0.00 | -0.02 | - | -0.02 | -0.01 | -0.04 |
| Weighted Average Shares Outstanding | 40.38 Million | 484.85 Thousand | 484.85 Thousand | 484.85 Thousand | 484.85 Thousand | 484.85 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 40.38 Million | 484.85 Thousand | 484.85 Thousand | 484.85 Thousand | 484.85 Thousand | 484.85 Thousand |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -5300.00 | -10.67 Thousand | - | -8750.00 | -3750.00 | -19.75 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
0571
INTUCH
5604
CRTO
BIOGY
ANSC